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ABSTRACT
OBJECTIVE
To determine how the UK National Health Service 
(NHS) is performing relative to health systems of other 
high income countries, given that it is facing sustained 
financial pressure, increasing levels of demand, and 
cuts to social care.
DESIGN
Observational study using secondary data from key 
international organisations such as Eurostat and 
the Organization for Economic Cooperation and 
Development.
SETTING
Healthcare systems of the UK and nine high income 
comparator countries: Australia, Canada, Denmark, 
France, Germany, the Netherlands, Sweden, 
Switzerland, and the US.
MAIN OUTCOME MEASURES
79 indicators across seven domains: population and 
healthcare coverage, healthcare and social spending, 
structural capacity, utilisation, access to care, quality 
of care, and population health.
RESULTS
The UK spent the least per capita on healthcare in 
2017 compared with all other countries studied (UK 
$3825 (£2972; €3392); mean $5700), and spending 
was growing at slightly lower levels (0.02% of gross 
domestic product in the previous four years, compared 
with a mean of 0.07%). The UK had the lowest rates of 
unmet need and among the lowest numbers of doctors 
and nurses per capita, despite having average levels 
of utilisation (number of hospital admissions). The UK 
had slightly below average life expectancy (81.3 years 
compared with a mean of 81.7) and cancer survival, 
including breast, cervical, colon, and rectal cancer. 
Although several health service outcomes were 
poor, such as postoperative sepsis after abdominal 
surgery (UK 2454 per 100 000 discharges; mean 
2058 per 100 000 discharges), 30 day mortality for 
acute myocardial infarction (UK 7.1%; mean 5.5%), 
and ischaemic stroke (UK 9.6%; mean 6.6%), the UK 
achieved lower than average rates of postoperative 
deep venous thrombosis after joint surgery and fewer 
healthcare associated infections.
CONCLUSIONS
The NHS showed pockets of good performance, 
including in health service outcomes, but spending, 
patient safety, and population health were all below 
average to average at best. Taken together, these 
results suggest that if the NHS wants to achieve 
comparable health outcomes at a time of growing 
demographic pressure, it may need to spend more to 
increase the supply of labour and long term care and 
reduce the declining trend in social spending to match 
levels of comparator countries.
Introduction
The UK’s spending on healthcare has been constrained 
for some time, with slow growth in spending in 
a setting of steadily increasing demand as the 
population ages and other safety nets for the older 
population are cut.1 From 2010 to 2017, the number 
of people aged over 80 rose by 340 000. In the same 
period, real public spending on social care fell by 1% 
and spending on adult social care fell by 6.4%.2 As a 
result of the great fiscal pressure facing the National 
Health Service (NHS), there has been an increased 
effort to improve the efficiency of the health system by 
various means including, but not limited to, reductions 
in reimbursement rates, staff freezes, and cuts to 
administrative and prescribing costs.3 4 Since 2009 
productivity in the NHS has risen faster than in other 
sectors of the British economy, but recent strikes have 
brought matters such as staffing gaps, inadequate pay, 
and patient safety to global attention.5
The UK NHS is not the only health system facing 
the challenge of having to meet growing demand from 
patients while under pressure to reduce healthcare 
costs.6 However, few studies have looked abroad to 
understand whether other healthcare systems can 
provide lessons for the NHS.4 7 Where comparisons 
exist, they often focus on specific aspects of the system, 
such as spending, cancer care, or quality, and show a 
mixed picture of relative performance. Fortunately, 
new national data have become available over the 
past few years that allow for a careful comparison 
not just of spending but also of broader health system 
performance including access, quality, and outcomes. 
Comparative data on how the UK performs relative to 
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WHAT IS ALREADY KNOWN ON THIS TOPIC
The UK National Health Service (NHS) has faced sustained financial pressures 
while handling increasing demand
Cuts to social care have coincided with an increase in the population of older 
people
The NHS has increased productivity and efficiency in recent years, but it still 
faces substantial challenges
WHAT THIS STUDY ADDS
The UK spent the least per capita on healthcare in 2017 compared with nine high 
income comparator countries, and spending was growing at slightly lower levels
Factors contributing to the relatively low expenditure in the UK include lower 
levels of staffing, lower rates of utilisation, and less provision of long term care 
than comparators
The NHS showed pockets of good performance, including in health service 
outcomes, but spending, patient safety, and population health were all below 
average to average at best
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other high income countries across a set of important 
metrics would be helpful but have been lacking.
Therefore, in this study, using comparable data 
from several international organisations including 
the Organization for Economic Cooperation and 
Development (OECD), we sought to compare the UK 
health system with those of nine other countries across 
seven main domains: population and healthcare 
coverage, health and long term care spending, 
structural capacity, utilisation, access, quality, and 
population health. Our hypothesis was that if austerity 
has harmed the NHS, we would see this in higher 
population and patient dissatisfaction, drops in access 
and utilisation, and worsening quality and population 
health status. If, however, we continue to see 
comparable performance and trends of performance in 
line with other countries also trying to meet changes 
in sociodemographics, this probably suggests a health 
system that has been able to cut waste and operate more 
efficiently than other high spenders. Unfortunately, 
comparative detailed data on the performance of the 
NHS across the four constituent countries of the UK 
(England, Scotland, Northern Ireland, and Wales), 
where the NHS is structured differently, are not 
available. Therefore, we examined UK performance as 
a whole. Given the greater population size of England, 
the performance metrics we report will be dominated 
by the performance of the English NHS.
Methods
Selection of study and comparator countries
We examined the UK and nine comparator high income 
countries. Data for the UK represent the NHS and not 
the privately financed healthcare sector. Moreover, 
although the NHS is structured differently across the 
four countries of the UK, particularly when it comes to 
the provision of social care (often referred to as long 
term care), in this paper we consider the performance of 
all these systems together. Given the greater population 
size of England, the UK performance metrics reported 
in this study are dominated by the performance of the 
English NHS.
We chose the comparator countries because they 
are all high income countries, are members of the 
G12, and have populations with similar demographic 
characteristics that face similar burdens of illness, 
but also have healthcare systems that are structured 
in different ways.8 On the basis of these criteria, we 
compared the UK with the US, Canada, Germany, 
Australia, Sweden, France, Denmark, the Netherlands, 
and Switzerland. The comparator countries represent 
different geographical areas and diverse health system 
structures. In addition, we compared all performance 
metrics with the OECD average and the EU average to 
allow for a broader comparison.
Data sources
Data came from a range of databases compiled by 
international organisations, with most coming from 
the OECD. Data on spending, structural capacity, 
workforce, utilisation, access, and quality came from 
OECD.stat and the OECD Health at a Glance reports. 
Additional data came from the World Bank, the 
Institute for Health Metrics Evaluation, and Eurostat. 
We gathered perceptions of health systems, staff 
satisfaction, unmet need, time spent with general 
practitioner, patient-general practitioner experiences, 
care continuity, and waiting time indicators from 
various Commonwealth Fund international surveys, 
including the Surveys of Primary Care Physicians, 
the Health Policy Surveys of Older Adults, and the 
International Health Policy Surveys.
We translated all data on remuneration into US 
dollar equivalents, with exchange rates based on 2016 
purchasing power parities of national currencies.9 
When data were not available for a given country, or 
more accurate country level estimates were available, 
we used country specific data sources. For example, 
to highlight the differences in total healthcare 
expenditure in the UK between the OECD’s System 
of Health Accounts (SHA) classification of healthcare 
spending and the previous accounting methods 
used, we used health spending data from the Office 
for National Statistics. Detailed descriptions of all 
variables and what they capture is included in the 
supplementary technical appendix.
Selection of variables
To better understand the UK’s healthcare performance 
relative to other high income countries, we reviewed 
a range of variables. We first examined comparative 
data on the size and make-up of the populations of 
the different countries and their rates of healthcare 
coverage. We then compared spending on health and 
long term care, including the proportion of spending 
coming from public and private sources. As countries 
organise their benefit packages for health and long term 
care differently, with some countries drawing different 
boundaries between what is and is not funded from the 
healthcare budget, we used data from the OECD’s SHA 
classification as a basis for comparison. This includes 
all spending on health related components of long 
term care, regardless of which national budget they are 
included in or whether they are public, private, or out 
of pocket.
Next, we examined comparative inputs, including 
workforce and structural capacity such as hospital 
beds, which aside from contributing to direct costs 
may also influence maintenance costs or the cost of 
using equipment. Given current debates in the UK 
about migration, we also included descriptive statistics 
on the percentage of migrants represented in the 
healthcare workforce and in the general population. In 
recent years, policy makers in the UK have advocated 
for more efficiency gains in the healthcare system or, in 
other terms, the transformation of existing healthcare 
expenditures into the same amount of, or more, 
health system outcomes. We therefore extended our 
analysis to examine a range of intermediate outputs—
namely, access and utilisation, patients’ and general 
practitioners’ experience, and quality of care—as well 
as indicators of population health status, such as life 
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expectancy and mortality amenable to healthcare to 
examine the change in performance of these areas over 
a period of reduced growth in healthcare spending. 
We standardised all data on structural capacity and/or 
utilisation to the population or patient, and all health 
service outcome data were adjusted for age and sex by 
the OECD. Details on all indicators can be found in the 
technical appendix.
To provide a broader context of overall factors that 
can contribute to differences in healthcare spending 
and consider the UK debate about recent austerity 
measures and their effect on NHS demand, we also 
examined social spending more broadly (that is, 
spending on social programmes, specifically on 
unemployment, family, old age, incapacity, survivors, 
housing, and active labour market programmes), 
as well as demographic differences, risk factors, 
and prevalence of disease. In line with previous 
international comparisons, the healthcare system 
included all groups of which the primary intent is to 
improve health.10
This approach resulted in the presentation of a total 
of 79 indicators across seven domains: population 
and healthcare coverage, health and long term 
care spending, structural capacity, access to care, 
utilisation, quality of care, and population health. 
In each domain, we selected measures that were 
available across most of the countries in the analysis. 
In the area of quality, the focus was on indicators that 
captured quality of prevention, primary care, and 
inpatient care, across the areas of appropriateness, 
effectiveness, experience, and safety. In the area of 
access, we explored variations related to waiting times 
and unmet need for healthcare.
The focus of our analysis was on indicators from 
2017, as well as the trends in data from 2010 when 
available and comparable. If data from either 2017 or 
2010 were not available, we used the nearest available 
year (for example, data from 2016 instead of 2017). 
We note aspects of comparability and timeliness for 
each indicator in the technical appendix. In each table, 
we present the average of each indicator across all 10 
countries including the UK, along with the averages of 
OECD and European Union member countries.
Patient and public involvement
There was no patient or public involvement in this 
research.
Results
Population and healthcare coverage
The make-up of the UK population, in terms of size of 
total population and the percentage of the population 
over 65 years of age was similar to the study average 
(population in UK, 66.4 million; study average, 64.7 
million; population over 65 in the UK, 18%; study 
average, 19%) (table 1). Rates of growth for these 
metrics in the UK were similar to the study average as 
well. The proportion of the population over 65 in the 
UK was slightly greater than the mean of the OECD 
member nations (17%), but equal to the mean of EU 
member nations (18%). The UK reported among the 
lowest rate of adults with multiple chronic conditions 
(UK, 14%; study average, 18%). The percentage 
of the total population born outside of the country 
was slightly lower in the UK than in our comparator 
countries in 2017 (UK, 14.2%; study average, 17.1%), 
although it was quite close to the average OECD and 
EU member state (OECD average, 13.8%; EU average, 
13.2%). However, the increase in the foreign born 
population from 2010 was above the average among 
comparators (UK, 2.9%; study average, 1.8%), and 
much higher than both the OECD average (0.7%) 
and the EU average (0.9%), particularly among the 
population coming from the EU. Among comparator 
countries, the UK had among the highest proportions 
of the foreign born population coming from the EU, 
after Switzerland, although this was in line with the 
averages of all OECD and EU member states.
All countries with the exception of the US were similar 
in terms of having nearly 100% of the population with 
healthcare coverage (table 1). Rates of private health 
insurance coverage varied widely across countries. This 
is largely explained by the different function of private 
insurance coverage across the countries. For example, 
private insurance in the UK largely reflects duplicative 
private insurance policies that allow people to access 
private healthcare in addition to the NHS. In Germany, 
the private insurance is mostly substitutive and reflects 
contributions from people who have opted out of the 
statutory health insurance system and whose main 
form of coverage is the private healthcare system. In 
France, health insurance reflects complementary add-
on policies that allow individual reductions in co-pays 
or increased accessibility to particular drugs, services, 
or both. However, private insurance coverage in the UK 
was below the average of the comparator countries, as 
well as the OECD and EU member state average (UK, 
10%; study average, 52%; OECD average, 35%; EU 
average, 32%) and had declined over the previous 
decade (UK, −1%; study average, 1%; OECD average, 
2%; EU average, 3%). These numbers do not reflect the 
range of services covered or the depth of coverage.
Healthcare and social spending
The UK had the lowest healthcare expenditure per 
capita relative to our comparator countries (UK, $3825 
(£2972; €3392); study average, $5700), although 
this was roughly in line with the average healthcare 
expenditure of the OECD member states ($3854) and the 
EU member states ($3616) (table 2). The OECD reports 
per capita spending for the UK to be $3943, which also 
reflects components of social care that are included in 
expenditures for other countries (supplementary figure 
A). Expressed as a proportion of gross domestic product 
(GDP), the picture was similar, with the UK spending 
approximately 8.7% of GDP compared with the study 
average of 11.5% of GDP in 2017 (fig 1). Even if long 
term care (referred to as social care) expenditures are 
included in healthcare spending to allow for a more 
similar comparison across countries, UK expenditure 
remains below the comparator average (9.8% of GDP) 
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(supplementary figure A). As illustrated in figure 1 (and 
supplementary figure A), the rate of growth in total 
healthcare expenditure in the UK has fluctuated across 
the past two decades. Despite always spending a lower 
proportion of GDP than the average of the comparator 
countries, before 2009 healthcare expenditure in 
the UK grew faster than the average of the other nine 
countries. This was particularly pronounced during 
the period of 2000-09, reflecting the commitment of 
the Blair government to match UK NHS spending to 
the European average.11 12 From 2009 onwards, the 
growth in UK healthcare expenditure slowed to its 
lowest levels whereas health expenditure growth in the 
comparator countries was notably higher, averaging a 
rate of 0.08% of GDP per year over the period 2011-14 
compared with an average annual decrease of 0.03% 
of GDP in the UK, and a rate of 0.07% of GDP over the 
period 2014-17 in comparator countries compared 
with a rate of 0.02% of GDP in the UK.
The proportion of healthcare expenditures in the 
UK coming from public sources (general taxation 
and national insurance contributions, referred to as 
government/compulsory spending by the OECD) is 
close to the average of the comparator countries (UK, 
79%; study average, 80%), but slightly higher than the 
averages of OECD and EU member states (OECD, 74%; 
EU, 75%). In recent years in the UK, this spending has 
declined and been replaced by funding from private 
sources (−4% over the period 2010-17). The average 
trend across the comparator countries has been the 
reverse, with a shift away from private funds to public 
funds shown by a mean of 4%. This is higher than the 
increase across the OECD (an increase of 1%) and the 
EU member states (a decrease of 1%).
Total per capita spending on long term care in the 
UK was below the study average, but slightly above the 
average long term care expenditure across the OECD 
and EU. Social spending in the UK as a percentage of 
Table 1 | Healthcare coverage and population statistics for UK and comparator countries, 2017 and change from 2010
Study average OECD average EU average UK AUS CAN FRA GER NLD SWE CHE US DEN
Population
Total population, millions 64.7 36.2 18.3 66.4 24.9 37.1 66.9 82.9 17.2 10.2 8.5 327.2 5.8
 Change 3.3 1.6 0.4 3.7 2.9 3.1 2.2 1.1 0.6 0.80 0.7 17.8 0.3
Population over 65, % 19 17 18 18 16 17 20 21 19 20 18 16 19
 Change 2 2 2 2 2 3 3 1 4 2 1 3 3
Adults with multiple chronic conditions, % 18 NA NA 14 15 22 18 17 14 18 15 28 -
Foreign born, % 17.1 13.8 13.2 14.2 27.9 19.7 11.9 15.4 12.5 17.7 29.3 13.5 11.1
 Change 1.8 0.7 0.9 2.9 1.9 0.7 2.5 1.4 3.5 3.1 1.0 3.7
Foreign born from EU, % 30.1 34.4 33.8 34.6 31.9 26.0 26.7 32.7 25.1 28.4 56.2 7.3 31.7
 Change −0.4 2.6 0.9 3.1 −6.2 −1.1 −1.4 1.7 3.0 −5.9 2.0 −1.4 2.4
Health insurance
Population covered by government/social 
health insurance, %
93 93 98 100 100 100 99.9 89.4 99.9 100 100 36 100
 Change 1 −2 1 0 0 0 0 0.4 0.3 0 0 5 0
Population covered by private health 
insurance, %
52 35 32 10 54 67 96 34 84 NA 29 63 29
 Change 1 2 3 −1 2 −1 −0.3 3 −5 - 0.6 2 8
AUS=Australia; CAN=Canada; CHE=Switzerland; DEN=Denmark; FRA=France; GER=Germany; NA=not available; NLD=Netherlands; OECD=Organization for Economic Cooperation and 
Development; SWE=Sweden.
Values are 2017 or nearest year. Change represents difference from 2010 (or nearest year) values.
Table 2 | Healthcare and social spending in UK and comparator countries, 2017 and change from 2010
Study average OECD average EU average UK AUS CAN FRA GER NLD SWE CHE US DEN
Healthcare spending
Per capita healthcare spending, 1000s 
US$
5700 3854 3616 3825 4791 4812 4931 5848 5155 5264 7147 10 207 5025
 Change 1222 775 629 583 1195 645 883 1436 682 1818 1851 2267 864
Government/compulsory expenditure, % 
of total health expenditure
80 74 75 79 69 70 83 84 82 84 64 85* 84
 Change 4 1 −1 −4 0.3 −0.4 7 1 −2 2 2 36* 0.1
Voluntary/out-of-pocket expenditure, % 
of total health expenditure
20 26 25 21 31 30 17 16 18 16 36 15* 16
 Change -4 −1 1 4 −0.3 0.4 −7 −1 2 −2 −2 −36* −0.1
Total long term care expenditure, per 
capita, current US$
930 633 573 738 100 734 750 1070 1366 1392 1381 511 1257
 Change 184 150 106 69 57 60 168 411 274 213 357 56 238
Social spending
Total social spending, % GDP 20.1 16.9 18.8 19.6 16.8 13.5 25.1 19.1 22.0 23.6 19.0 16.1 26.5
 Change 0.3 −0.1 −0.4 −1.7 2.7 −0.2 0.7 −0.9 0.6 0.7 0.9 −0.1 0.2
Public social spending, % GDP 15.7 14.8 17.2 13.9 12.2 10.3 23.2 16.8 15.0 20.1 12.9 10.4 22.3
 Change 0 −0.2 −0.4 −1.5 1.4 0.1 0.7 −1.1 0.4 0.1 0.5 −0.9 0.3
AUS=Australia; CAN=Canada; CHE=Switzerland; DEN=Denmark; FRA=France; GDP=gross domestic product; GER=Germany; NLD=Netherlands; OECD=Organization for Economic Cooperation and 
Development; SWE=Sweden.
Values are 2017 or nearest year. Change represents difference from 2010 (or nearest year) values.
*In 2014 in US, employer provided health insurance was reclassified as compulsory expenditure whereas it had previously been classified as voluntary expenditure.
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GDP was 19.6%, which was similar to the study average 
of 20.1% but above the OECD average (16.9%) and the 
EU average (18.8%). However, UK social spending had 
been declining at a faster rate than all three groups 
over the previous five years. In addition, the relative 
proportion of public social spending decreased, 
whereas the proportion of public social spending in 
comparator countries remained relatively constant.
Structural capacity
The number of practising physicians in the UK was 
below the study average in 2017 (UK, 2.8; study 
average, 3.5 doctors/1000 population), and also 
lower than both the OECD and EU averages (OECD, 
3.4; EU, 3.5 doctors/1000 population) (table 3). 
Although the UK had a comparable number of 
medical graduates to the average of the comparators 
(UK, 12.9; study average 12.5 graduates/100 000 
population) it also had the greatest decrease in 
graduates from 2010 to 2017 (UK, −0.7; study average, 
1.7 graduates/100 000 population). Across the OECD 
and the EU, the numbers of medical graduates were 
slightly higher and had been increasing over the 
previous decade. The number of practising nurses 
in the UK in 2017 was considerably lower than 
all comparator countries and below the OECD and 
EU averages (UK, 7.8; study average, 11.4; OECD, 
9.3; EU, 8.5 nurses/1000 population). We chose 
practising nurses rather than professionally active 
nurses owing to availability of data. Additionally, the 
UK was the only country to experience a decrease in 
the number of nurses from 2010 to 2017 (UK, −0.6; 
study average, 0.4; OECD, 0.9; EU, 0.5 nurses/1000 
population). The numbers of nursing graduates in the 
UK were nearly half the number of nursing graduates 
in comparator countries (UK 29.4; study average 
56/100 000 population) and lower than the OECD 
(44.3/100 000 population) and EU (37.4/100 000 
population) averages. The numbers of general 
practitioners and specialists in the UK were similar to 
those in all other countries.
The proportion of foreign trained doctors as a 
percentage of total doctors in the UK in 2017 was 
greater than the mean of comparators and higher 
than the OECD and EU average (UK, 28.6%; study 
average, 21.4%; OECD, 18.2%; EU, 12.4%) (table 3). 
This was also true for nurses, with foreign trained 
nurses representing 15% of the workforce in the UK 
in 2017 (study average, 9.3%; OECD, 6%; EU, 3.2%). 
Recent figures on migration of health professionals 
for the UK show that the annual inflow of EU doctors 
and nurses has fallen since 2015. The annual inflow 
of doctors from the EU decreased from a high of 3326 
in 2014 to 2064 in 2017, but these numbers were 
more than compensated for by an inflow of doctors 
from outside the EU (fig 2, bottom). The total annual 
inflow of nurses sharply decreased by 62% from 9168 
in 2016 to 3462 in 2017 (fig 2, top). Whereas the 
annual inflow of nurses from outside the EU increased 
from 931 in 2016 to 2648 in 2017, the annual inflow 
of nurses from the EU decreased from 8237 in 2016 
to 814 in 2017 (fig 2, top). Additionally, the stock of 
foreign trained nurses has declined; more than 3000 
EU nurses left the NHS in 2017 (supplementary figure 
B, right). Although numbers of nurses from outside the 
EU are increasing, this is not at a rate that compensates 
for the significant decreases in nurses coming from EU 
member nations.
The UK had the lowest percentage of physicians 
who were dissatisfied with the time they were able to 
spend with patients (UK, 2%; study average, 13%) and 
was tied with Canada and Netherlands for the lowest 
Year
Average annual growth rate (%)
G
D
P
 (
%
)
0
4
6
10
8
12
2
1998 2000 2002 2004 2006 2008 2010 2012 2014 2016
0.22
0.23
0.09
0.23
0.07
0.20
0.23
0.17
0.08
-0.03
0.07
0.02
United Kingdom
Average of comparator countries
Average of comparator countries
United Kingdom
OECD average
EU average
Fig 1 | Total expenditure on health in UK, comparator countries, Organization for Economic Cooperation and 
Development (OECD) member nations, and European Union (EU) member nations. Values for average annual growth 
rates are for indicated 4 year periods and are shown only for UK and average of comparator countries. Values for UK 
came from Office for National Statistics because they are consistent with years before implementation of System of 
Health Accounts (SHA) in 2011. More detailed information on SHA and differences between two accounting methods 
can be found in online technical appendix. An alternative to this figure, which has OECD reported values under SHA 
classifications for UK, is also available in supplementary figure A. GDP=gross domestic product
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percentage of physicians who were dissatisfied with 
their income (UK, 20%; study average, 32%). The 
UK had fewer total hospital beds per population than 
the average of all comparator groups (UK, 2.5; study 
average, 4; OECD, 4.7; EU, 4.8 beds/1000 population) 
(table 3). The number of beds in the UK decreased at a 
rate similar to the averages. The trends were similar for 
the numbers of beds for mental health services. Finally, 
remuneration of specialists and nurses in the UK was 
slightly below the average of the comparator countries 
(UK specialists, $171 987; study average specialists, 
$182 657; UK nurses, $49 725; study average nurses, 
$57 946), but remuneration of general practitioners 
was similar to the mean of the group (UK, $134 671; 
study average, $133 721) (supplementary figure C).
Utilisation
The UK had slightly fewer total consultations with 
doctors per capita compared with other comparator 
countries (UK, 5; study average, 5.7; OECD, 6.4; EU, 
6.8 visits/person/year) and lower rates of all cause 
hospital discharges (UK, 12 354; study average, 
14 919; OECD, 15 235; EU, 16 218 discharges/100 000 
population), which were also decreasing at a faster rate 
than the average (table 4). Primary care physicians in 
the UK reported spending the least amount of time with 
patients, with 0% spending 25 or more minutes with 
patients (study average, 15%), 8% reporting spending 
15-25 minutes (study average, 45%), and 92% 
reporting spending less than 15 minutes with their 
patients (study average, 38%). The rate of influenza 
immunisation among the population over age 65 
was higher in the UK than in all comparator groups 
(UK, 72.6%; study average, 54.1%; OECD 43.2%; EU 
37.2%) with the exception of Australia (74.6%). Rates 
of breast cancer screening for women aged 50-69 and 
cervical cancer screening for women aged 20-69 were 
higher in the UK than the average for the comparator 
countries (breast: UK, 75.1%; study average, 66.5%; 
OECD, 61.5%; EU 63.9%; cervical: UK, 75.4%; study 
average, 71%, OECD, 63.6%; EU, 64.9%). However, 
both UK screening rates decreased at faster rates than 
the study average (table 4). Average length of hospital 
stay in the UK was 6.8 days, which was very close to 
the study average of 6.7 days and lower than the OECD 
average (7.3 days) and the EU average (7.4 days). 
Length of hospital stay for childbirth was 2.5 days in 
the UK, which was lower than the study average (3.2 
days), the OECD average (3.5 days), and the EU average 
(3.6 days).
Table 3 | Structural capacity in UK and comparator countries, 2017 and change from 2010
Study average OECD average EU average UK AUS CAN FRA GER NLD SWE CHE US DEN
Doctors
Practising, per 1000 population 3.5 3.4 3.5 2.8 3.7 2.7 3.2 4.3 3.6 4.1 4.0 2.6 4.0
 Change 0.3 0.3 0.3 0.2 0.4 0.4 0.1 0.5 0.2 0.2 0.5 0.2 0.3
Medical graduates, per 1000 
population
12.5 13.0 14.6 12.9 15.5 7.7 9.5 12.0 13.5 11.5 11.2 7.8 21.5
 Change 1.7 2.7 2.9 −0.7 3.4 0.5 3.7 −0.1 2.3 1.1 0.8 1.1 5.0
Nurses
Practising, per 1000 population 11.4 9.3 8.5 7.8 11.7 10.0 10.8 12.9 10.9 11.0 17.2 11.7 10
 Change 0.4 0.9 0.5 −0.6 1.5 0.6 0.1 2.4 1.4 0.6 −0.1 2.6 0.1
Nursing graduates, per 1000 
population
56 44.3 37.4 29.4 84.5 52.5 40.8 54.5 53.0 39.2 100.9 61.7 44
 Change 6.8 4.4 1.9 1.9 17 1.1 4.0 9.4 13.7 −4.3 24.4 −3.5 3.8
Workforce by type of care
General practitioners, per 1000 
population
1.1 1 1 0.8 1.6 1.3 1.4 1 1.6 0.7 1.1 0.3 0.8
 Change 0.1 0.1 0 0 0.1 0.2 −0.2 0.1 0.4 0 0.5 0 0
Specialists, per 1000 population 2.2 2.2 2.5 2.1 1.8 1.4 1.7 3.3 2 2.2 2.6 2.3 1.8
 Change 0.3 0.3 0.3 0.2 0.3 0.2 0.1 0.4 0.3 0.2 0.1 0.2 0.2
Foreign workforce
Foreign trained doctors, % of total 
doctors)
21.4 18.2 12.4 28.6 32.1 24.6 11.2 11.9 2.2 34.8 34.1 25 9.2
 Change 3 2.1 2.7 −1.1 −1 1.5 3.8 5.3 −0.4 11.2 9.9 0.2 0.5
Foreign trained nurses, % of total 
nurses
9.3 6 3.2 15 18.4 8.1 2.9 7.9 0.5 3 25.9 6 1.8
 Change 1.8 0.7 0.2 1.6 1.2 0.9 0.4 1.7 −0.6 0.4 11.2 −0.2
Staff satisfaction
Physicians dissatisfied with 
income, %
32 NA NA 20 25 20 63 33 20 28 42 32 -
Physicians dissatisfied with time 
with patients, %
13 NA NA 2 10 23 8 23 12 22 4 16 -
Beds
Total, per 1000 population 4 4.7 4.8 2.5 3.8 2.5 6 8 3.3 2.2 4.5 2.8 2.6
 Change −0.5 −0.3 −0.5 −0.4 0.1 −0.3 −0.5 −0.3 −0.9 −0.5 −0.4 −0.3 −0.9
Mental health, per 1000 popu-
lation
0.7 0.7 0.7 0.4 0.4 0.3 0.8 1.3 0.9 0.4 0.9 0.2 0.5
 Change −0.1 −0.1 −0.1 −0.2 0.03 −0.02 −0.04 0.1 −0.4 −0.05 −0.04 −0.04 −0.1
AUS=Australia; CAN=Canada; CHE=Switzerland; DEN=Denmark; FRA=France; GER=Germany; NA=not available; NLD=Netherlands; OECD=Organization for Economic Cooperation and 
Development; SWE=Sweden.
Values are 2017 or nearest year. Change represents difference from 2010 (or nearest year) values.
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Access to care
Waiting times across the UK were for the most part 
comparable to the average of the 10 countries, although 
considerable variation existed across the group. Sixty 
five per cent of UK patients reported seeing the doctor 
or nurse the next day when they last needed care, 
compared with an average of 67% across the countries 
(table 5). Twenty four per cent reported waiting six days 
or more for an appointment, compared with an average 
of 20% across the countries. UK waiting times were 
slightly longer for specialist care, with 19% reporting 
waiting two months or longer, compared with a group 
average of 12%, but fewer patients reported visiting 
the emergency department for a condition that could 
have been treated by a regular doctor (UK, 7%; study 
average, 9%). The UK had the lowest rates for each 
category pertaining to unmet need, which included 
the percentage of adults having any cost related access 
problem (UK, 7%; study average 15%), skipping a 
medical test, treatment, or follow-up owing to cost 
(UK, 3%; study average 8%), and skipping prescribed 
drugs owing to costs (UK, 2%; study average, 8%). 
However, the proportion of adults skipping prescribed 
drugs owing to costs has risen since 2010 in the UK, 
despite decreasing in other countries.
Quality of care
We examined various aspects of quality of care across 
the 10 countries, including indicators related to 
patients’ and providers’ experience and health service 
outcomes such as mortality and adverse events. The 
UK population had a similar perception of how well the 
NHS functions compared with other populations’ views 
about their healthcare systems. Specifically, 44% of UK 
adults reported that they thought the healthcare system 
worked well (compared with the study average of 45%), 
although this had declined by 19 percentage points 
since 2010 (table 6). Other national surveys of the UK 
population, such as the British Attitudes Survey, show 
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Fig 2 | Annual inflow of foreign trained workforce in UK. Top: Annual inflow of foreign 
trained nurses into UK. Bottom: Annual inflow of foreign trained doctors into UK. All 
data are presented as foreign trained workforce from European Union (EU) nations, non-
EU nations, and total
Table 4 | Healthcare utilisation in UK and comparator countries, 2017 and change from 2010
Study average OECD average EU average UK AUS CAN FRA GER NLD SWE CHE US DEN
Doctor visits
Total No of consultations, per 
capita
5.7 6.4 6.8 5 6.6 7 6.7 9.9 6.6 2.9 3.9 4 4.6
Hospital discharges
All causes, per 100 000 
population
14 919 15 235 16 218 12 354 17 996 8,461 18 609 25 478 9247 12 937 17 069 12 549 14 492
 Change −378 −457 −933 -856 1105 185 1736 1485 −2690 −3314 157 −542 −1584
Time spent with patient during routine visit
<15 minutes, % of GPs 38 NA NA 92 28 30 5 80 85 2 8 16 -
15 to <25 minutes, % of GPs 45 NA NA 8 66 53 72 16 14 49 68 63 -
≥25 minutes, % of GPs 15 NA NA 0 5 16 21 2 0 48 24 20 -
Immunisation
65+ receiving flu vaccine, % 54.1 43.2 37.2 72.6 74.6 61.1 49.7 34.8 64 49.4 46 67.5 40.8
 Change -6.4 −1.5 −2.5 −0.2 - 1.7 −6.5 −21.3 −10 −5.8 - 3.6 −4.8
Cancer screening
Breast, % of women 50-69 66.5 61.5 63.9 75.1 55.1 54 49.7 51 79.3 90.4 49 79.5 82.1
 Change 2.2 3.3 4.3 −1.7 −0.8 0.2 −3 −2.7 −2.2 0 - −0.9 4.7
Cervical, % of women 20-69 71 63.6 64.9 75.4 55.4 61 75.4 80.4 56.9 82.9 75.5 83.3 63.5
 Change -0.1 3.7 6 −3.5 −2.4 −3 4.3 1.7 −8.6 2.8 1.9 −1.7 −1.4
Length of stay
Total (all causes, inpatient), 
days
6.7 7.3 7.4 6.8 5.6 8 8.8 8.9 4.5 5.6 8.2 4.8 5.4
 Change −0.1 −0.1 −0.2 −0.6 −0.2 0.3 −3.1 −0.6 −1.1 −0.4 −0.8 −0.1 −0.5
Childbirth, days 3.2 3.5 3.6 2.5 3.2 2.3 4.3 3.8 2.7 2.6 4.1 2.8 2.9
 Change −0.3 −0.1 −0.3 0.1 −0.2 −0.1 −0.4 −0.7 −0.5 −0.1 −0.7 0 −0.4
AUS=Australia; CAN=Canada; CHE=Switzerland; DEN=Denmark; FRA=France; GER=Germany; GP=general practitioner; NA=not available; NLD=Netherlands; OECD=Organization for Economic 
Cooperation and Development; SWE=Sweden.
Values are 2017 or nearest year. Change represents difference from 2010 (or nearest year) values.
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a growing consensus among the general population 
that the NHS faces a major or severe funding problem 
(86% of respondents in 2017, up from 14% in 2014).13 
General practitioners’ views of the health system were 
not as favourable as in comparator countries, with only 
22% of primary care physicians reporting that they 
thought the healthcare system worked well (compared 
with the study average of 33%). Moreover, the number 
of primary care physicians reporting that the system 
worked well in 2015 had decreased by 24 percentage 
points from 2012, compared with a mean change of 8 
percentage points across all 10 countries (table 6).
A smaller proportion of the UK population reported 
experiencing a problem with care coordination and 
a gap in hospital discharge planning than in all other 
study countries (UK, 19% and 28%, respectively; 
Table 5 | Access to healthcare in UK and comparator countries, 2017 and change from 2010
Study average OECD average EU average UK AUS CAN FRA GER NLD SWE CHE US
Waiting times
Saw doctor or nurse on next day last time needed care, % 67 NA NA 65 71 45 83 81 76 53 69 57
Waited ≥6 days appointment, % 20 NA NA 24 9 29 22 34 8 28 12 18
Waited ≥2 months for specialist  appointment, % 12 NA NA 19 13 30 4 3 7 19 9 6
Visited ED for condition that could have been treated by 
regular doctor, %
9 NA NA 7 6 17 7 5 6 12 9 16
 Change 2 NA NA 3 −1 2 3 2 0 2 1 3
Unmet need
Any cost related access problem in  previous year, % of adults 15 NA NA 7 14 16 17 7 8 8 22 33
 Change 7 NA NA 2 6 7 14 0 2 4 16 14
Medical tests, treatment, or follow-up skipped owing to 
costs, % of adults
8 NA NA 3 4 6 10 4 9 4 13 20
 Change −0.2 NA NA −0.3 −10.3 0.3 3.3 −5.1 6.4 −0.9 7.8 −3.2
Prescribed drugs skipped owing to costs, % of adults 8 NA NA 2 8 11 8 3 7 7 12 18
 Change −0.1 NA NA 0.4 −4.8 0.3 0.5 −2.9 3.3 −1.7 7.5 −3.9
AUS=Australia; CAN=Canada; CHE=Switzerland; ED=emergency department; FRA=France; GER=Germany; NA=not available; NLD=Netherlands; OECD=Organization for Economic Cooperation and 
Development; SWE=Sweden.
Values are 2017 or nearest year. Change represents difference from 2010 (or nearest year) values.
Table 6 | Quality of care in UK and comparator countries, 2017 and change from 2010
Study average OECD average EU average UK AUS CAN FRA GER NLD SWE CHE US DEN
Population satisfaction
Think healthcare system works well, % of adults 45 NA NA 44 44 35 54 60 43 31 58 19 -
 Change 4 NA NA −19 −4 −7 14 18 −8 −13 4 −6 -
GP experience
Think healthcare system works well, % of physicians 33 NA NA 22 48 36 29 27 50 19 54 16 -
 Change −8 NA NA −24 3 −4 −8 5 −4 −20 8 −30 -
Care continuity
Experienced problem with care coordination, % 27 NA NA 19 22 30 31 19 23 32 30 35 -
 Change 0.8 NA NA −5 1 −2 24 −22 2 8 1 0 -
Experienced gap in hospital discharge planning, % 39 NA NA 28 29 40 60 28 47 52 45 22 -
 Change −10 NA NA −10 −12 −4 6 −28 −12 −15 −11 −6 -
Avoidable admissions
Diabetes, per 100 000 population aged ≥15 122 138 135 73 141 94 151 218 70 96 73 191 113
 Change −14 −22 −23 0 8 −3 −42 −14 −2 −42 3 - −33
COPD, per 100 000 population aged ≥15 204 194 194 232 307 233 120 255 166 165 111 172 282
 Change 0 −4 −7 −15 −10 −9 29 38 13 −15 16 - −9
Mortality
AMI, rate/100 patients 5.5 7.6 7.1 7.1 4.0 5.1 5.6 7.7 5.4 4.2 5.1 6.5 4.0
 Change −1.0 −1.0 −1.2 −1.1 −1.1 −2.4 −0.6 −1.9 −1.8 −0.6 −0.8 1.0 −0.9
Ischaemic stroke, rate/100 patients 6.6 8.4 8.9 9.6 6.7 8.5 7.1 6.2 7.3 6.1 5.4 4.1 4.6
 Change −1.6 −0.9 −0.9 −2.2 −3.4 −2.8 −1.4 −0.7 −1.1 −0.6 −1.6 −0.2 −2.0
Patient safety
Postoperative pulmonary embolism after hip or knee 
replacement, per 100 000 discharges
330 286 246 316 549 657 267 341 - 166 339 294 -
 Change 19 −60 −32 −7 −5 31 −44 58 - −18 74 - -
Postoperative DVT after hip or knee replacement, per 
100 000 discharges
489 347 351 202 1113 311 1328 419 - 90 237 209 -
 Change −215 −119 −115 −39 −58 −28 −809 −203 - −44 −45 - -
Postoperative sepsis after abdominal surgery, per 
100 000 discharges
2058 1821 1949 2454 2658 1365 - 1862 - 1352 2371 2129 2269
 Change 618 236 253 850 467 131 - 317 - 205 1268 - 1017
Healthcare associated infections, % prevalence 6.6 NA 5.5 5.2 - - 4.9 5 7.4 7.3 - - 9.8
AMI=acute myocardial infarction; AUS=Australia; CAN=Canada; CHE=Switzerland; COPD=chronic obstructive pulmonary disease; DEN=Denmark; DVT=deep venous thrombosis; FRA=France; 
GER=Germany; GP=general practitioner; NA=not available; NLD=Netherlands; OECD=Organization for Economic Cooperation and Development; SWE=Sweden.
Values are 2017 or nearest year. Change represents difference from 2010 (or nearest year) values.
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study averages, 27% and 39%, respectively) (table 6). 
Although the UK had fewer avoidable admissions to 
hospitals for diabetes among the adult population (UK, 
73; study average, 122; OECD, 138; EU, 135/100 000 
population), it had more avoidable admissions for 
chronic obstructive pulmonary disease (UK, 232; 
study average, 204; OECD, 194; EU, 194/100 000 
population). Thirty day mortality for acute myocardial 
infarction in the UK was among the highest relative to 
comparator countries (7.1%; study average, 5.5%), 
after Germany (7.7%), although it was comparable 
to the average OECD and EU rates (7.6% and 7.1%, 
respectively). The UK also had the highest three day 
mortality for ischaemic stroke (UK, 9.6%; study average, 
6.6%; OECD, 8.4%; EU, 8.9%). However, both of these 
mortality rates declined to a greater extent from 2010 
values in the UK compared with the group average.
The UK performed slightly better than the study 
average for measures of patient safety, including 
postoperative pulmonary embolism after hip or knee 
replacement (UK, 316; study average, 330; OECD, 
286; EU, 246/100 000 discharges), postoperative 
deep venous thrombosis (UK, 202; study average, 
489; OECD, 347; EU, 351/100 00 discharges), and 
the prevalence of healthcare associated infections 
(UK, 5.2%; study average, 6.6%). However, rates 
were higher for postoperative sepsis after abdominal 
surgery (UK, 2454; study average, 2058; OECD, 1821; 
EU, 1949/100 000 discharges) (table 6).
Population health
Life expectancy at birth in the UK was just below the 
average of the comparator countries (UK, 81.3 years; 
study average, 81.7 years) (fig 3). Life expectancy in 
the UK has been below the average over the past 20 
years, although the gap narrowed over the period 
2008-13 to a low of 0.3 years (fig 2). Owing to recent 
increases in mortality in the UK in 2014-15, this gap 
once again increased, although it seems to be closing 
again as life expectancy improved in 2016 and 2017. 
As a result of large improvements in the UK in recent 
years, smoking rates in 2017 were below average 
compared with comparator countries, the OECD, and 
the EU (UK, 16.1%; study average, 16.5%; OECD, 
18.4%; EU, 20.1%). The rate of alcohol consumption 
was about average, and the prevalence of overweight 
and obesity was above average relative to comparators 
(alcohol consumption: UK; 9.7; study average, 9.3; 
OECD, 8.9; EU, 10 L per capita; overweight and obesity: 
UK, 64%; study average, 54.7%; OECD, 55.1%; EU, 
54.6%) (table 7).
Among the European countries where preventable 
deaths and treatable deaths are measured, the UK 
had greater than average rates of preventable deaths 
compared with the study average (UK, 154; study 
average, 139 deaths/100 000 population), and the 
highest rates of amenable deaths (UK, 90; study 
average, 72 deaths/100 000 population). However, the 
UK performed similarly to the average of the EU (161 
and 93 deaths/100 000 population for preventable and 
treatable causes, respectively) (table 7). Improvements 
in each of these measures over the previous five 
years in the UK was below the average improvement 
of the group. Maternal mortality in the UK was 7.8 
deaths/100 000 live births, which was greater than the 
mean of the comparators (5.5 deaths/100 000 births) 
and above the OECD and EU averages (7.0 and 6.4 
deaths/100 000 births, respectively); this represents 
an increase from 2010 values by 0.8 deaths (table 7). 
The UK had similar rates of infant mortality to other 
countries (UK, 3.9; study average, 3.8; OECD, 3.7; EU, 
3.2 deaths/1000 live births), and they are decreasing 
at a similar rate to the average (UK, −0.3 deaths; study 
average, −0.2 deaths). The only countries with higher 
rates of infant deaths were Canada (4.5 deaths/1000 
live births) and the US (5.8 deaths/1000 live births). 
The UK had the lowest survival rates for breast cancer 
(UK, 85.6%; study average, 87.4%) and colon cancer 
(UK, 60%; study average, 64.8%), and the second 
lowest for rectal cancer (UK, 62.5%; study average, 
66.6%) and cervical cancer (UK, 63.8%; study average 
66.6%). Prevalence of diabetes was lower in the UK 
than the average of the group (UK, 4.3%; study average, 
6.3%; OECD, 6.5%; EU, 6.1%), but the prevalence 
of depression and dementia were about average 
(depression: UK, 2.9%; study average, 2.8%; OECD, 
2.6%; EU, 2.6%; dementia: UK; 17; study average, 
16.4; OECD, 14.8; EU, 15.8 per 1000 population).
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Fig 3 | Total population life expectancy at birth in UK, average of comparator countries, average of Organization for 
Economic Cooperation and Development (OECD) member countries, and average of European Union (EU) member 
countries
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Discussion
In this study, based on aggregated data from recent 
years, the UK was consistently the country that spent 
the least on healthcare per capita compared with 
nine other high performing health systems. When 
compared with the 35 member states of the OECD 
and the 28 member states of the EU, UK healthcare 
spending was about average. Relative to other 
countries, the NHS has lower amounts of labour, which 
have been decreasing at a faster rate, particularly after 
2015, when large decreases in the annual inflow of 
EU trained healthcare professionals have been seen. 
Despite spending less than comparators, the UK NHS 
manages to achieve universal population coverage 
with perceptions of access that were among the highest 
of all countries examined, while utilisation of care 
was lower than the average of comparators. However, 
health service outcomes and measures of population 
health status are among the lowest in the group and 
have worsened over the past decade. Taken together, 
these results suggest that, if the UK NHS wants to 
achieve comparable health outcomes to other high 
income countries, or even improve outcomes, it needs 
to invest more on factors that can reverse the decline 
of health service outcomes and health status overall. 
In particular, our study suggests that the NHS should 
look towards improving staffing ratios, long term care 
provision, and social spending, which are lower than 
comparator countries and have been declining in 
recent years.
Contribution to previous studies and common 
narratives on NHS performance
Our findings shed light on some of the most 
common narratives about the current challenges 
facing the NHS by taking a comparative perspective 
to put national numbers into context. A few key 
findings warrant highlighting. Although the UK 
has comparable numbers of people over the age of 
65, it spends less of its already low total healthcare 
expenditure on long term care. Furthermore, a much 
greater proportion of long term care expenditure 
in the UK comes from private sources than in 
other healthcare systems. Finally, the UK seems to 
have much higher rates of informal care than the 
comparator countries, with high proportions of the 
workforce reporting that they are out of work or in 
part time employment because they are providing 
care.14 In 2017 long term care made up the second 
largest category of private household spending 
in the UK, accounting for 36% of out of pocket 
spending, after spending on medical goods which 
accounted for 38%.15 In both healthcare and areas 
of social spending, expenditures coming from the 
Table 7 | Population health in UK and comparator countries, 2017 and change from 2010
Study average OECD average EU average UK AUS CAN FRA GER NLD SWE CHE US DEN
Non-medical determinants of health
Smoking, % of adults ≥15 16.5 18.4 20.1 16.1 12.4 14 22.4 20.9 19 11.2 20.4 11.4 17
 Change −8.3 −7.3 −6.7 −10.9 −7.2 −8.4 −4.6 −3.8 −13 −7.7 −6 −7.7 −13.5
Alcohol consumption, L per capita ≥15 9.3 8.9 10 9.7 9.4 8.1 11.7 10.9 8.3 7.1 9.2 8.9 9.1
 Change −0.5 −0.4 −0.5 −0.4 −0.9 −0.3 −0.6 −0.5 −0.8 −0.2 −0.8 0.3 −1.2
Overweight including obesity, % of total popu-
lation
54.7 55.1 54.6 64 65 60 46 53 47 48 42 71 51
 Change 1.6 2.7 1.6 −2 −2 0.5 3.2 0.3 −1 2 1 2 4.3
Avoidable mortality
Preventable deaths, per 100 000 population 139 NA 161 154 - - 133 158 134 121 111 - 161
 Change −11 NA −14 −5 - - −14 −6 −7 −6 −12 - −23
Treatable deaths, per 100 000 population 72 NA 93 90 - - 62 87 69 68 53 - 76
 Change −9 NA −10 −4 - - −5 −8 −10 −10 −10 - −15
Maternal/infant mortality
Maternal mortality, per 100 000 births 5.5 7.0 6.4 7.8 1.6 6.6 8.7 2.9 1.8 3.5 4.6 17.2 1.6
 Change −0.5 −2.1 −0.6 0.8 −2.7 0.2 −1.5 −2.3 −0.4 0.9 0.9 0.5 −3.5
Infant mortality, per 1000 live births 3.8 3.7 3.2 3.9 3.3 4.5 3.9 3.3 3.6 2.4 3.5 5.8 3.8
 Change −0.2 −0.7 −0.5 −0.3 −0.8 −0.5 0.4 −0.1 −0.2 −0.1 −0.3 −0.3 0.4
Cancer survival
Breast cancer survival, 5 year net % 87.4 84.7 83.2 85.6 89.5 88.2 86.7 86 86.6 88.8 86.2 90.2 86.1
 Change 0.7 1.1 1.1 1.8 1.0 0.7 −0.5 0.4 0.8 0.9 −0.2 0.4 2.1
Cervical cancer survival, 5 year net % 66.6 65.7 63.6 63.8 66.4 66.6 65 65.2 67.5 68.3 71.4 62.6 69.5
 Change 1.0 0.4 0.6 1.9 −1.1 −0.3 2.9 −0.5 2.0 0.6 2.0 −0.4 2.8
Colon cancer survival, 5 year net % 64.8 62.4 60.5 60 70.6 66.9 63.7 64.8 63 64.9 67.2 64.9 61.6
 Change 1.7 1.9 2.2 3.5 2.5 1.3 0.1 −0.1 2.1 0.6 2.1 −0.6 5.1
Rectal cancer survival, 5 year net % 66.6 65.7 63.6 62.5 71 66.6 60.9 62.2 65.3 64.7 67.3 64.1 64.8
 Change 1.0 0.4 0.6 3.8 2.4 1.2 0.2 0 2.2 1.7 1.6 −0.4 5
Prevalence of chronic conditions
Depression prevalence, % 2.8 2.6 2.6 2.9 3.3 2.2 3.3 2.6 2.6 3.3 2.5 3.2 2
 Change −0.1 0 0 0 −0.3 0 −0.1 0.1 0 −0.1 −0.1 −0.1 0
Diabetes prevalence, % ages 20-79 6.3 6.5 6.1 4.3 5.1 7.4 4.8 8.3 5.3 7.6 5.6 10.8 6.4
Dementia prevalence, per 1000 population 16.4 14.8 15.8 17 14 13 20 20 16 18 17 12 16
AUS=Australia; CAN=Canada; CHE=Switzerland; DEN=Denmark; FRA=France; GER=Germany; NA=not availble; NLD=Netherlands; OECD=Organization for Economic Cooperation and Development; 
SWE=Sweden.
Values are 2017 or nearest year. Change represents difference from 2010 (or nearest year) values.
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public purse are declining and greater amounts are 
coming from private sources.
The role of migrants in the NHS has been a 
considerable focus in recent years, with regards 
to increasing demand pressures on the NHS from 
migrants as healthcare users, but also in terms of 
their role as providers of care. We found that both 
in absolute magnitude and as a proportion of the 
population, migrants in the UK make up less of 
the population than the average of comparator 
countries. Unless migrants coming to the UK are 
somehow dramatically sicker than those going to 
other similar countries, they are unlikely to be putting 
disproportionately greater pressure on healthcare 
demand in the UK than elsewhere. When it comes 
to the healthcare workforce, we found that the UK 
had among the highest proportion of foreign trained 
doctors and nurses. Despite this, the numbers of all 
types of healthcare professionals reported (general 
practitioners, specialists, and nurses) were some of the 
lowest of all countries studied, and the numbers are 
declining. As the migration of healthcare professionals 
has decreased since 2015, as evidenced by an 87% 
drop in new nurses coming from the EU to work in the 
UK from 2016-17 to 2017-18,16 the existing staffing 
challenges facing the NHS will clearly be further 
exacerbated. Policy makers should consider how 
recent changes to nursing bursaries, the weakened 
pound, and uncertainty about the status of immigrant 
workers in the light of the Brexit referendum result 
have influenced these numbers and how to respond to 
these challenges in the future.
Other aspects of structural capacity in the UK NHS 
compared with other health systems suggest problems 
with sustainability of care. The numbers of beds in 
the UK are at the lower end of the distribution of 
comparator countries and well below the average of 
the OECD and the EU. Although pay for doctors has 
been a major focus in the media, we found that relative 
to other countries the remuneration of doctors was 
about average, both in terms of nominal pay and as 
a ratio to the national wage. Moreover, physicians in 
the UK were less likely to report being dissatisfied with 
their incomes than were those in many comparator 
countries. Pay for nurses in the UK, however, was lower 
than the average across countries in both nominal and 
relative terms.
With regards to access to care, we found that the UK 
had average waiting times for specialist and primary 
care. Although the total number of consultations and 
hospital admissions in the UK was slightly below the 
average, it was not the lowest, despite having some of 
the lowest staffing levels. UK primary care physicians 
reported spending less time with their patients 
than did all other comparators. Ratings of patient 
experience and population satisfaction were similar to 
those in other countries, but have declined by a large 
amount in recent years, and a lower number of general 
practitioners in the UK than in other countries reported 
experiencing problems with continuity of care for their 
patients.
One of the biggest ongoing debates about the NHS has 
to do with the extent to which services are able to cope 
with government cuts to long term care funding and 
sluggish NHS funding. With the exception of patient 
safety measures, for which the UK performed slightly 
better than average on most measures, we found that 
most health service outcomes were below average 
and, in many cases, were the lowest of the group. 
Mortality rates for acute myocardial infarction and 
ischaemic stroke were the second highest and highest 
respectively. Compared with the wider OECD and EU 
averages, they were average at best. Cancer survival 
rates were the lowest of the comparator countries for 
breast and colon cancer, with cervical and rectal cancer 
survival being the second lowest. Maternal mortality 
in the UK was higher than for all comparators except 
the US and Germany, and is increasing. The numbers 
of preventable and treatable deaths in the population 
were the third highest and highest respectively. These 
findings may represent the difficulty of delivering the 
full set of services in a constrained setting with fewer 
providers and beds: the quality of the service may be 
beginning to suffer.
This analysis extends a body of work that has 
examined recent funding cuts in the NHS and their 
effect on performance. Many local reports in the 
academic literature and the media have noted the 
effect that funding cuts have had on emergency 
waiting times, hospital emergency alerts over winter 
months, and delayed discharge.13 This work shows 
that relative to other countries, the UK is also lagging 
behind with regards to many health service outcomes 
and population health measures, confirming other 
findings such as the poor comparative cancer 
outcomes highlighted in recent reports, despite large 
improvements in recent years.4
Limitations of study
This study has several limitations. Firstly, the data 
presented in this paper are purely descriptive; we did 
no statistical analyses to determine whether the UK’s 
performance was statistically different from that of 
the comparator countries. In some cases, differences 
between countries and over time were small and may 
have been influenced by the comparability of patients 
and supply-side factors across countries and over time. 
Secondly, the data available to provide a true “apples 
with apples” comparison were limited. To ensure the 
validity of the data presented, we selected indicators 
from sources that have well established processes for 
validating national data with country representatives. 
Thirdly, our paper presents aggregate data for all of 
the UK, which does not take into account the large 
differences that exist in the NHS across the four 
constituent countries in the UK—namely, England, 
Scotland, Wales, and Northern Ireland. This was largely 
to do with the difficulty in finding comparable data 
across these countries. Finally, our main comparison 
is with nine other countries, all of which spend more 
on healthcare than the UK does. Perhaps our relative 
assessment of the UK would be more favourable had 
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a different set of countries been chosen, representing 
a group that spends a closer proportion of GDP on 
their healthcare systems to the UK, such as Portugal, 
Spain, and Italy. We chose to focus the comparison on 
a group of countries that we believe the UK tends to 
liken itself to,7 17 almost all part of the G12 and very 
high income. However, to show the sensitivity of the 
interpretation to the selection of comparator countries, 
we also show the comparison of UK performance with 
the average performance of all OECD countries and all 
EU countries.
Conclusion and policy implications
We examined 79 health systems metrics in the UK and 
nine comparable countries and found that the UK had 
lower spending and slower growth in expenditure than 
comparators. Several factors contribute to the relatively 
low expenditure in the UK, including lower levels of 
doctor and nurse staffing, lower rates of utilisation, 
and less provision of long term care than comparators. 
Despite already low levels of labour, the UK is making 
do with fewer doctors and nurses, a challenge that 
is likely to be exacerbated in the context of Brexit. 
Although access to care compared favourably to other 
countries, utilisation was lower than average and 
quality seems to be slipping. Health service outcomes, 
as well as heath status, are suboptimal. This work 
suggests that although the NHS has done a remarkable 
job in managing the constrained funding environment, 
the broader challenges are such that if the UK wants an 
NHS that remains high performing and a nation with 
good health outcomes, it will almost certainly need to 
spend more on healthcare staffing, long term care, and 
other social services, which lag behind comparators.
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